Study Preview
Study Title and Description
Randomized comparison of the suprapubic arc sling procedure vs tension-free vaginal taping for stress incontinent women.
Key Questions Addressed
1 | Sling vs Comparator RCT outcomes (excluding AEs) | |
2 | Sling Adverse Events |
Primary Publication Information
Title | Randomized comparison of the suprapubic arc sling procedure vs tension-free vaginal taping for stress incontinent women. |
Author | Tseng LH., Wang AC., Lin YH., Li SJ., Ko YJ. |
Country | Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics/Gynecology, Chang Gung University Hospital, Guei-shan Tao-yuan, Taiwan. |
Year | -- Not Found -- |
Numbers |
Pubmed ID: 15875240 71 (internal) |
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Sling vs Comparator RCT outcomes (excluding AEs)
Arms
Number | Title | Description | Comments |
---|---|---|---|
1 | SPARC | • SPARC as described by Plzak and Staskin | |
2 | TVT | TVT – as per standard technique described by Ulmsten |
Question... Follow Up | Answer | Follow-up Answer | |
---|---|---|---|
Country ... | Other ... | Taiwan | |
Outcome Categories Reported | Objective SUI | ||
OR outcomes/complications (not "AEs") | |||
Population (reason for surgery etc.) | Symptomatic SUI | ||
Urodynamic SUI | |||
RCT Comparison Category ... | Other comparison ... | retropubic SPARC vs. retropubic TVT | |
Multicenter | No | ||
Institution Type | Academic hospital | ||
Number of surgeons performing procedures | 1 | ||
Surgeons' Training | Urogynecology | ||
Residents or fellows performing surgery? | No | ||
Study Quality (overall) | B (fair) | ||
Overall Study Notes | Multiple soft red flags: out of 72 consecutive slings, 62 met inclusion criteria and were randomized, that means no pts declined to participate. Computer generated randomization, but exactly equal number of patients in 2 arms. There are no missing data, suspicious given a lack of info regarding how these datapoints were defined or collected. | ||
Study Sponsor/Funding ... | Other ... | none listed so I assume academia |
Baseline Characteristics
Question | SPARC | TVT | SPARC | TVT | Total | Comments | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Answer | Follow-up | Answer | Follow-up | Answer | Follow-up | Answer | Follow-up | Answer | Follow-up | ||
No. Randomized | 31 | 31 | |||||||||
Mean Age | 50.43yr | 51.57yr | |||||||||
Post-Op Follow-Up Interval (Maximum) | 2yr | 2yr |
Results & Comparisons
Results Data
Outcome: Nocturia Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | SPARC vs. TVT |
2 years |
N Enrolled | 31 | 31 | ||||
Counts | 2 | 1 | |||||
Standard Deviation | |||||||
1.00 | |||||||
0 years |
N Enrolled | ||||||
Counts | |||||||
Standard Deviation |
Outcome: Frequency Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | SPARC vs. TVT |
0 years |
N Enrolled | ||||||
Counts | |||||||
Standard Deviation | |||||||
. | |||||||
2 years |
N Enrolled | 31 | 31 | ||||
Counts | 5 | 3 | |||||
Standard Deviation | |||||||
.706 |
Outcome: Urgency Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | SPARC vs. TVT |
2 years |
N Enrolled | 31 | 31 | ||||
Counts | 5 | 3 | |||||
Standard Deviation | |||||||
.706 | |||||||
0 years |
N Enrolled | ||||||
Counts | |||||||
Standard Deviation | |||||||
Outcome: Urge incontinence Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | SPARC vs. TVT |
0 years |
N Enrolled | ||||||
Counts | |||||||
Standard Deviation | |||||||
2 years |
N Enrolled | 31 | 31 | ||||
Counts | 5 | 2 | |||||
Standard Deviation | |||||||
.424 |
Outcome: Dysuria Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | SPARC vs. TVT |
2 years |
N Enrolled | 31 | 31 | ||||
Counts | 1 | 0 | |||||
Standard Deviation | |||||||
1.000 | |||||||
0 years |
N Enrolled | ||||||
Counts | |||||||
Standard Deviation | |||||||
Outcome: Incomplete voiding Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | SPARC vs. TVT |
0 years |
N Enrolled | ||||||
Counts | |||||||
Standard Deviation | |||||||
2 years |
N Enrolled | 31 | 31 | ||||
Counts | 10 | 6 | |||||
Standard Deviation | |||||||
.382 |
Outcome: Strain to void Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | SPARC vs. TVT |
2 years |
N Enrolled | 31 | 31 | ||||
Counts | 3 | 2 | |||||
Standard Deviation | |||||||
1.000 | |||||||
0 years |
N Enrolled | ||||||
Counts | |||||||
Standard Deviation | |||||||
Outcome: Post-micturition dribble Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | ERROR vs. ERROR |
0 years |
N Enrolled | ||||||
Counts | |||||||
Standard Deviation | |||||||
2 years |
N Enrolled | 31 | 31 | ||||
Counts | 4 | 0 | |||||
Standard Deviation | |||||||
.112 |
Outcome: SUI objective cured pad test Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | SPARC vs. TVT |
2 years |
N Enrolled | 31 | 31 | ||||
Counts | 25 | 27 | |||||
Standard Deviation | |||||||
.706 | |||||||
0 years |
N Enrolled | ||||||
Counts | |||||||
Standard Deviation | |||||||
Outcome: SUI objective improved pad test Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | ERROR vs. ERROR |
0 years |
N Enrolled | ||||||
Counts | |||||||
Standard Deviation | |||||||
2 years |
N Enrolled | 31 | 31 | ||||
Counts | 6 | 4 | |||||
Standard Deviation | |||||||
.706 |
Outcome: Operation time Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | SPARC vs. TVT |
0 years |
N Analyzed | 31 | 31 | ||||
Mean | 40.77min | 32.74min | |||||
Standard Deviation | |||||||
.779 | |||||||
2 years |
N Analyzed | ||||||
Mean | |||||||
Standard Deviation |
Outcome: Hospital days Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | SPARC vs. TVT |
2 years |
N Analyzed | 31 | 31 | ||||
Mean | 3.97d | 3.14d | |||||
Standard Deviation | |||||||
.030 | |||||||
0 years |
N Analyzed | ||||||
Mean | |||||||
Standard Deviation | |||||||
Outcome: Blood loss Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | SPARC vs. TVT |
0 years |
N Analyzed | 31 | |||||
Mean | 135.83 | 106.00 | |||||
Standard Deviation | |||||||
.510 | |||||||
2 years |
N Analyzed | ||||||
Mean | |||||||
Standard Deviation | |||||||
Extraction Form: Sling Adverse Events
Arms
Number | Title | Description | Comments |
---|---|---|---|
1 | SPARC | ||
2 | TVT |
Question... Follow Up | Answer | Follow-up Answer | |
---|---|---|---|
Study Type | RCT | ||
Study Country ... | Other ... | Taiwan | |
Sling Category | Retropubic synthetic | ||
Multicenter? | No | ||
Institution Type | Academic hospital | ||
No. of Surgeons Performing the Procedures | 1 | ||
Surgeons' Training | Urogynecology | ||
Residents or Fellows Performing the Surgery? | No | ||
Adverse Event Ascertainment | Unclear/Not reported | ||
Was the Clavien-Dindo Classification of Surgical Complications system used? | No / Not reported | ||
Was a data safety monitoring board used? | No / Not reported | ||
Study Sponsor/Funding ... | Other ... | I assume academia | |
Not reported |
Results & Comparisons
Results Data
Outcome: Nocturia Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | SPARC vs. TVT |
2 years |
N Enrolled | 31 | 31 | ||||
Counts | 2 | 1 | |||||
Standard Deviation | |||||||
1.00 | |||||||
0 years |
N Enrolled | ||||||
Counts | |||||||
Standard Deviation |
Outcome: Frequency Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | SPARC vs. TVT |
0 years |
N Enrolled | ||||||
Counts | |||||||
Standard Deviation | |||||||
. | |||||||
2 years |
N Enrolled | 31 | 31 | ||||
Counts | 5 | 3 | |||||
Standard Deviation | |||||||
.706 |
Outcome: Urgency Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | SPARC vs. TVT |
2 years |
N Enrolled | 31 | 31 | ||||
Counts | 5 | 3 | |||||
Standard Deviation | |||||||
.706 | |||||||
0 years |
N Enrolled | ||||||
Counts | |||||||
Standard Deviation | |||||||
Outcome: Urge incontinence Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | SPARC vs. TVT |
0 years |
N Enrolled | ||||||
Counts | |||||||
Standard Deviation | |||||||
2 years |
N Enrolled | 31 | 31 | ||||
Counts | 5 | 2 | |||||
Standard Deviation | |||||||
.424 |
Outcome: Dysuria Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | SPARC vs. TVT |
2 years |
N Enrolled | 31 | 31 | ||||
Counts | 1 | 0 | |||||
Standard Deviation | |||||||
1.000 | |||||||
0 years |
N Enrolled | ||||||
Counts | |||||||
Standard Deviation | |||||||
Outcome: Incomplete voiding Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | SPARC vs. TVT |
0 years |
N Enrolled | ||||||
Counts | |||||||
Standard Deviation | |||||||
2 years |
N Enrolled | 31 | 31 | ||||
Counts | 10 | 6 | |||||
Standard Deviation | |||||||
.382 |
Outcome: Strain to void Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | SPARC vs. TVT |
2 years |
N Enrolled | 31 | 31 | ||||
Counts | 3 | 2 | |||||
Standard Deviation | |||||||
1.000 | |||||||
0 years |
N Enrolled | ||||||
Counts | |||||||
Standard Deviation | |||||||
Outcome: Post-micturition dribble Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | ERROR vs. ERROR |
0 years |
N Enrolled | ||||||
Counts | |||||||
Standard Deviation | |||||||
2 years |
N Enrolled | 31 | 31 | ||||
Counts | 4 | 0 | |||||
Standard Deviation | |||||||
.112 |
Outcome: SUI objective cured pad test Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | SPARC vs. TVT |
2 years |
N Enrolled | 31 | 31 | ||||
Counts | 25 | 27 | |||||
Standard Deviation | |||||||
.706 | |||||||
0 years |
N Enrolled | ||||||
Counts | |||||||
Standard Deviation | |||||||
Outcome: SUI objective improved pad test Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | ERROR vs. ERROR |
0 years |
N Enrolled | ||||||
Counts | |||||||
Standard Deviation | |||||||
2 years |
N Enrolled | 31 | 31 | ||||
Counts | 6 | 4 | |||||
Standard Deviation | |||||||
.706 |
Outcome: Operation time Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | SPARC vs. TVT |
0 years |
N Analyzed | 31 | 31 | ||||
Mean | 40.77min | 32.74min | |||||
Standard Deviation | |||||||
.779 | |||||||
2 years |
N Analyzed | ||||||
Mean | |||||||
Standard Deviation |
Outcome: Hospital days Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | SPARC vs. TVT |
2 years |
N Analyzed | 31 | 31 | ||||
Mean | 3.97d | 3.14d | |||||
Standard Deviation | |||||||
.030 | |||||||
0 years |
N Analyzed | ||||||
Mean | |||||||
Standard Deviation | |||||||
Outcome: Blood loss Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | SPARC | TVT | SPARC | TVT | Comparison Measure | SPARC vs. TVT |
0 years |
N Analyzed | 31 | |||||
Mean | 135.83 | 106.00 | |||||
Standard Deviation | |||||||
.510 | |||||||
2 years |
N Analyzed | ||||||
Mean | |||||||
Standard Deviation | |||||||
Adverse Events
Arm or Total | Title | Description | Follow-up time | In-hospital or After discharge | Is event serious? | Reported definition of serious event | Number affected | Number at risk (analyzed) | Difference between 2 slings (eg, OR/RR or %, with 95% CI) | Reported P value between slings | Comments |
---|---|---|---|---|---|---|---|---|---|---|---|
SPARC | Organ injury in OR (urethra, bladder, bowel) | Bladder Injury | 4 | 31 | .112 | ||||||
TVT | 0 | 31 | |||||||||
Total | |||||||||||
SPARC | Retropubic hematoma(>/= 5cm) | 3 | 31 | .706 | |||||||
TVT | 5 | 31 | |||||||||
Total | |||||||||||
SPARC | REjection of tape | Rejection of tape was considered as including persistent defective healing of the vaginal wound despite debridement, exposure of the suburethral portion of the tape, spontaneous healing of the vaginal wound after removal of the exposed tape, and evidence of prosthesis rejection reaction demonstrated by immunohistochemical evaluation | 1 | 31 | 1.00 | ||||||
TVT | 2 | 31 | |||||||||
Total | |||||||||||
SPARC | Defective vaginal wound healing | Defective vaginal wound healing was defined as presentation of granulation background on the site of the polypropylene tape implantation in the anterior vaginal wall. | 1 | 31 | .612 | ||||||
TVT | 3 | 31 | |||||||||
Total | |||||||||||
SPARC | Protrusion of tape edge | Protrusion of the tape edge was defined as healing of the vaginal wound without any visible granulation background, with part of the unbound selvage edge of the tape being visible on the suburethral implantation site. | 1 | 31 | .112 | ||||||
TVT | 4 | 31 | |||||||||
Total | |||||||||||
SPARC | |||||||||||
TVT | |||||||||||
Total |